BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32809903)

  • 1. Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure.
    Griffin JM; Borlaug BA; Komtebedde J; Litwin SE; Shah SJ; Kaye DM; Hoendermis E; Hasenfuß G; Gustafsson F; Wolsk E; Uriel N; Burkhoff D
    J Am Heart Assoc; 2020 Sep; 9(17):e016760. PubMed ID: 32809903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
    Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
    J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction.
    Baratto C; Caravita S; Soranna D; Faini A; Dewachter C; Zambon A; Perego GB; Bondue A; Senni M; Badano LP; Parati G; Vachiéry JL
    Circ Heart Fail; 2021 May; 14(5):e007555. PubMed ID: 33951935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure.
    Eisman AS; Shah RV; Dhakal BP; Pappagianopoulos PP; Wooster L; Bailey C; Cunningham TF; Hardin KM; Baggish AL; Ho JE; Malhotra R; Lewis GD
    Circ Heart Fail; 2018 May; 11(5):e004750. PubMed ID: 29695381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
    Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
    ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction.
    Reddy YNV; Obokata M; Wiley B; Koepp KE; Jorgenson CC; Egbe A; Melenovsky V; Carter RE; Borlaug BA
    Eur Heart J; 2019 Dec; 40(45):3721-3730. PubMed ID: 31609443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.
    Borlaug BA; Nishimura RA; Sorajja P; Lam CS; Redfield MM
    Circ Heart Fail; 2010 Sep; 3(5):588-95. PubMed ID: 20543134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
    Wolsk E; Kaye D; Komtebedde J; Shah SJ; Borlaug BA; Burkhoff D; Kitzman DW; Lam CSP; van Veldhuisen DJ; Ponikowski P; Petrie MC; Hassager C; Møller JE; Gustafsson F
    JACC Heart Fail; 2019 Apr; 7(4):321-332. PubMed ID: 30852235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.
    Beale AL; Nanayakkara S; Segan L; Mariani JA; Maeder MT; van Empel V; Vizi D; Evans S; Lam CSP; Kaye DM
    JACC Heart Fail; 2019 Mar; 7(3):239-249. PubMed ID: 30819380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
    Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction.
    Koepp KE; Obokata M; Reddy YNV; Olson TP; Borlaug BA
    JACC Heart Fail; 2020 Aug; 8(8):657-666. PubMed ID: 32653449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-exercise left atrial conduit strain predicted hemodynamic change in heart failure with preserved ejection fraction.
    Cheng JF; Huang PS; Chen ZW; Huang CY; Lan CW; Chen SY; Lin LY; Wu CK
    Eur Radiol; 2024 Mar; 34(3):1825-1835. PubMed ID: 37650970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Fermoyle CC; Stewart GM; Borlaug BA; Johnson BD
    J Am Heart Assoc; 2021 Aug; 10(16):e019950. PubMed ID: 34369164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Borlaug BA; Melenovsky V; Koepp KE
    Circ Res; 2016 Sep; 119(7):880-6. PubMed ID: 27458234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Gorter TM; van Woerden G; Rienstra M; Dickinson MG; Hummel YM; Voors AA; Hoendermis ES; van Veldhuisen DJ
    JACC Heart Fail; 2020 Aug; 8(8):667-676. PubMed ID: 32653444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
    Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
    JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.